250 related articles for article (PubMed ID: 18499673)
1. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
Lauer-Fields JL; Whitehead JK; Li S; Hammer RP; Brew K; Fields GB
J Biol Chem; 2008 Jul; 283(29):20087-95. PubMed ID: 18499673
[TBL] [Abstract][Full Text] [Related]
2. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
[TBL] [Abstract][Full Text] [Related]
3. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
Lauer-Fields JL; Sritharan T; Stack MS; Nagase H; Fields GB
J Biol Chem; 2003 May; 278(20):18140-5. PubMed ID: 12642591
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
5. Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2).
Mikhailova M; Xu X; Robichaud TK; Pal S; Fields GB; Steffensen B
Matrix Biol; 2012; 31(7-8):380-8. PubMed ID: 23085623
[TBL] [Abstract][Full Text] [Related]
6. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
[TBL] [Abstract][Full Text] [Related]
7. New strategies for targeting matrix metalloproteinases.
Fields GB
Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
[TBL] [Abstract][Full Text] [Related]
8. Exosite interactions impact matrix metalloproteinase collagen specificities.
Robichaud TK; Steffensen B; Fields GB
J Biol Chem; 2011 Oct; 286(43):37535-42. PubMed ID: 21896477
[TBL] [Abstract][Full Text] [Related]
9. The role of collagen charge clusters in the modulation of matrix metalloproteinase activity.
Lauer JL; Bhowmick M; Tokmina-Roszyk D; Lin Y; Van Doren SR; Fields GB
J Biol Chem; 2014 Jan; 289(4):1981-92. PubMed ID: 24297171
[TBL] [Abstract][Full Text] [Related]
10. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
Stawikowski MJ; Stawikowska R; Fields GB
Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
[TBL] [Abstract][Full Text] [Related]
11. MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.
Bhaskaran R; Palmier MO; Lauer-Fields JL; Fields GB; Van Doren SR
J Biol Chem; 2008 Aug; 283(31):21779-88. PubMed ID: 18539597
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
[TBL] [Abstract][Full Text] [Related]
13. Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2.
Xu X; Chen Z; Wang Y; Yamada Y; Steffensen B
Biochem J; 2005 Nov; 392(Pt 1):127-34. PubMed ID: 16008524
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Minond D; Lauer-Fields JL; Nagase H; Fields GB
Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
[TBL] [Abstract][Full Text] [Related]
15. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
[TBL] [Abstract][Full Text] [Related]
16. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E; Imai K; Fujii Y; Sato H; Seiki M; Okada Y
J Biol Chem; 1997 Jan; 272(4):2446-51. PubMed ID: 8999957
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.
Tam EM; Moore TR; Butler GS; Overall CM
J Biol Chem; 2004 Oct; 279(41):43336-44. PubMed ID: 15292230
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.
Higashi S; Miyazaki K
J Biol Chem; 2008 Apr; 283(15):10068-78. PubMed ID: 18238779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
